Clinical Trial Update: A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab [Phase 2]

View source ↗

Summary

Clinical trial update reports termination of a Phase 2 long-term treatment study of Spesolimab for palmoplantar pustulosis and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• SPESOLIMAB (BI655130)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Palmoplantar Pustulosis | Phase 2 | Status: TERMINATED | Results posted: 2024-03-20